Average Co-Inventor Count = 7.02
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ortho-mcneil Pharmaceutical Corp. (7 from 363 patents)
2. Janssen Pharmaceutica Nv (5 from 2,078 patents)
3. Cellomics, Inc. (1 from 52 patents)
4. Janssen Pharmaceutica (1 from 32 patents)
14 patents:
1. 8278268 - Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
2. 8183213 - Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
3. 7853411 - System for cell-based screening
4. 7786135 - Substituted pyrroline kinase inhibitors
5. 7781450 - Substituted pyrroline kinase inhibitors
6. 7608634 - Substituted pyrrolines as kinase inhibitors
7. 7329657 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
8. 7304060 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
9. 7232906 - Substituted pyrrolines as kinase inhibitors
10. 7125878 - Substituted pyrroline kinase inhibitors
11. 6987110 - Substituted pyrrolines as kinase inhibitors
12. 6849643 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
13. 6838442 - Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
14. 6828327 - Macroheterocylic compounds useful as kinase inhibitors